1. Home
  2. HTBK vs EOLS Comparison

HTBK vs EOLS Comparison

Compare HTBK & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • EOLS
  • Stock Information
  • Founded
  • HTBK 1997
  • EOLS 2012
  • Country
  • HTBK United States
  • EOLS United States
  • Employees
  • HTBK N/A
  • EOLS N/A
  • Industry
  • HTBK Major Banks
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • EOLS Health Care
  • Exchange
  • HTBK Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • HTBK 588.2M
  • EOLS 589.3M
  • IPO Year
  • HTBK 1998
  • EOLS 2018
  • Fundamental
  • Price
  • HTBK $10.32
  • EOLS $9.21
  • Analyst Decision
  • HTBK Buy
  • EOLS Strong Buy
  • Analyst Count
  • HTBK 3
  • EOLS 5
  • Target Price
  • HTBK $11.33
  • EOLS $23.75
  • AVG Volume (30 Days)
  • HTBK 515.1K
  • EOLS 768.5K
  • Earning Date
  • HTBK 07-28-2025
  • EOLS 07-30-2025
  • Dividend Yield
  • HTBK 5.02%
  • EOLS N/A
  • EPS Growth
  • HTBK N/A
  • EOLS N/A
  • EPS
  • HTBK 0.68
  • EOLS N/A
  • Revenue
  • HTBK $174,083,000.00
  • EOLS $275,463,000.00
  • Revenue This Year
  • HTBK $9.79
  • EOLS $33.42
  • Revenue Next Year
  • HTBK $6.00
  • EOLS $33.18
  • P/E Ratio
  • HTBK $15.22
  • EOLS N/A
  • Revenue Growth
  • HTBK N/A
  • EOLS 25.38
  • 52 Week Low
  • HTBK $8.09
  • EOLS $8.67
  • 52 Week High
  • HTBK $11.27
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 61.46
  • EOLS 48.56
  • Support Level
  • HTBK $10.08
  • EOLS $9.12
  • Resistance Level
  • HTBK $10.44
  • EOLS $9.95
  • Average True Range (ATR)
  • HTBK 0.24
  • EOLS 0.31
  • MACD
  • HTBK -0.03
  • EOLS 0.03
  • Stochastic Oscillator
  • HTBK 60.00
  • EOLS 45.26

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: